Abdominal Aortic Aneurysm clinical trials at UCSF

6 in progress, 3 open to eligible people

An abdominal aortic aneurysm is a swelling in the main blood vessel of the abdomen. UCSF is studying the safety of using stents to treat this condition. Another study compares two kinds of devices for their effectiveness in treating aneurysms. A third trial collects data on how patients heal after getting endovascular treatment.

Showing trials for

  • Endovascular Exclusion of Thoracoabdominal And/or Paravisceral Abdominal Aortic Aneurysm

    open to eligible people ages 18 years and up

    This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

    San Francisco, California and other locations

  • Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

    open to eligible people ages 20 years and up

    The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.

    San Francisco, California and other locations

  • Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm

    open to eligible people ages 18 years and up

    To collect and analyze clinical follow-up data which can be used to assess the safety, efficacy, and durability of endovascular AAA repair with Zenith and Chuter-Gianturco stent-grafts.

    San Francisco, California and other locations

  • Nectero EAST System Clinical Study

    Sorry, not currently recruiting here

    The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.

    San Francisco, California and other locations

  • Post-Approval Study of the TREO Abdominal Stent-Graft System

    Sorry, in progress, not accepting new patients

    The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.

    Fresno, California and other locations

  • Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

    Sorry, not accepting new patients

    The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

    San Francisco, California and other locations

Our lead scientists for Abdominal Aortic Aneurysm research studies include .

Last updated: